Northrop Grumman recently reported its full-year 2025 results, with revenue rising to US$41.95 billion and net income reaching US$4.18 billion, alongside solid quarterly outperformance and a record backlog above US$95 billion fueled by substantial new defense awards.
Complementing these results, the company advanced key technologies such as its SMART Demo solid rocket motor and secured a US$233 million advanced lightweight torpedo contract with the US Navy and Australian Defense Force,...
Klarna Group (KLAR) is back in focus after multiple class action lawsuits accused the company of making false or misleading statements around loss reserve risks tied to its buy now, pay later loans during its September 2025 IPO.
See our latest analysis for Klarna Group.
The legal overhang appears to be weighing on sentiment, with Klarna’s 1 day share price return of negative 4.43% and 7 day share price return of negative 16.71%, and a 90 day share price return showing a 38.25% decline. This...
Why Guardant Health is on investors’ radar
Guardant Health (GH) is drawing attention after recent share price moves, with the stock showing a mix of short term fluctuations and stronger longer term returns that have some investors reassessing the precision oncology specialist.
See our latest analysis for Guardant Health.
The recent 3.2% 1 day share price return and 12.1% year to date share price return to US$114.04 sit alongside a 1 year total shareholder return of 142.7% and a 3 year total...
In January 2026, Axogen, Inc. completed a US$124,000,000 follow-on common stock offering of 4,000,000 shares at US$31 per share, while also filing an additional US$85,000,000 follow-on offering.
On the same day, Axogen filed a universal shelf registration covering common and preferred stock, debt securities, and warrants, expanding its flexibility to raise capital through multiple instruments.
We’ll now examine how Axogen’s expanded financing capacity through its universal shelf registration...
CareDx (CDNA) has been in focus after CEO John Hanna sold 19,480 shares under a Rule 10b5-1 plan, alongside fresh quarterly results showing 25% Q4 revenue growth and a new collaboration with 10x Genomics.
See our latest analysis for CareDx.
The recent 39.13% 3 month share price return, alongside a 7.37% 1 month move, suggests momentum has picked up again. However, the 1 year total shareholder return of an 11.80% decline and 5 year total shareholder return of a 76.84% decline highlight how...
Terrestrial Energy: Event Context and Recent Price Moves
Terrestrial Energy (IMSR) has been drawing attention after recent share price swings, with the stock up about 40% over the past month but showing a roughly 41% decline over the past 3 months.
See our latest analysis for Terrestrial Energy.
At a share price of $9.11, Terrestrial Energy has swung sharply in recent weeks, with a 7 day share price return of a 26.5% decline offsetting a 30 day share price return of 39.5%. The 1 year total...
Commerce Bancshares, Inc. reported fourth-quarter 2025 results showing higher net interest income of US$283.15 million and net income of US$140.66 million, alongside basic and diluted EPS of US$1.01, while net loan charge-offs eased to US$9.9 million.
During the same quarter, the bank repurchased 2,200,000 shares for US$117.24 million, completing a long-running buyback that has retired 43,972,309 shares since 2005, materially reshaping its share count over time.
Next, we will examine how...
WEC Energy Group (NYSE:WEC) has announced a Board leadership transition, with long time leader Gale Klappa retiring from the Board.
Scott Lauber is slated to become the new Chairman, while Klappa will receive the newly created title of Chairman Emeritus.
The Board has also approved a 6.7% change to the quarterly dividend, signaling continued focus on shareholder distributions.
For you as an investor, these updates sit on top of WEC Energy Group's role as a regulated utility serving...
In the past week, KE Holdings Inc. reported third-quarter 2025 results with revenues broadly in line with expectations and earnings coming in ahead of forecasts, despite ongoing pressure from China’s weak property market.
The company highlighted that efforts to improve operational efficiency and integrate AI across its leading Lianjia and Beike real estate platforms are expected to support meaningful margin improvements in 2026, reframing how investors assess its profitability potential...
In late January 2026, Best Western Hotels & Resorts and Tripadvisor launched “Go for the Goal,” an AI-powered platform that helps soccer fans plan complex multi-city trips around the 2026 international tournament, integrating hotel options near stadiums, route suggestions, and curated local experiences across the US, Canada, and Mexico.
This collaboration highlights how Tripadvisor is applying its data and AI capabilities to large-scale sports tourism, targeting fans who must coordinate...
In recent days, Principal Financial Group saw CEO Deanna D. Strable-Soethout sell 9,300 shares under a pre-arranged Rule 10b5-1 plan, while JPMorgan shifted its rating on the insurer to Neutral as part of a broader reassessment of life insurance stocks.
This combination highlights how sector-wide positioning by a major bank can influence sentiment toward Principal even when company-specific fundamentals are unchanged.
We’ll now examine how JPMorgan’s sector-driven downgrade shapes Principal...
In late January 2026, United Parcel Service reported fourth-quarter and full-year 2025 results, announced plans to cut up to 30,000 operational roles and close 24 facilities, and confirmed 2026 revenue guidance of about US$89.70 billion while maintaining a quarterly dividend of US$1.64 per share.
A key element of the update was UPS’s decision to sharply reduce low-margin Amazon volumes, pair that with higher goodwill and asset impairment charges of US$182 million, and accelerate automation...
Why Uniti Group’s new funding move matters for shareholders
Uniti Group (UNIT) recently completed an inaugural secured fiber network revenue term note offering of more than $960 million, giving the company additional capital for fiber investment and debt repayment across several key states.
See our latest analysis for Uniti Group.
The funding news arrives alongside a sharp shift in market tone, with a 1 day share price return of 10.64% and a 90 day share price return of 35.73% suggesting...
Netflix stock performance sets the stage for closer investor scrutiny
Netflix (NFLX) is drawing attention after a stretch of mixed returns, with the share price near US$83.49 and performance ranging from a 1 day gain to a decline over the past 3 months.
See our latest analysis for Netflix.
Recent trading has been choppy for Netflix, with a 1 day share price return of 0.40% sitting against a 90 day share price return of a 24.11% decline and a 1 year total shareholder return of a 14.52%...
Exelixis recently submitted a US FDA application for its next-generation cancer drug zanzalintinib, seeking approval in combination with Roche’s Tecentriq for previously treated metastatic colorectal cancer.
This filing highlights how Exelixis is leaning on its emerging pipeline to address future generic pressure on flagship therapy Cabometyx.
Next, we’ll examine how advancing zanzalintinib toward potential approval could influence Exelixis’ investment narrative and long-term oncology...
BCB Bancorp (BCBP) just posted its FY 2025 numbers with fourth quarter total revenue of US$14.0 million and a basic EPS loss of US$0.73, while trailing twelve month figures show total revenue of US$59.6 million and a basic EPS loss of US$0.84. Over recent periods, total revenue has shifted from US$23.3 million in Q3 2024 to US$19.0 million in Q4 2024 and then to US$14.0 million in Q4 2025, with quarterly EPS moving from US$0.36 to US$0.16 and then to a loss of US$0.73 over the same points in...